Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

China Pharma Holdings, Inc. to Report Second Quarter 2010 Financial Results on August 10, 2010

August 3, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

HAIKOU CITY, China , Aug. 3 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI ), which develops, manufactures, and markets specialty pharmaceutical products in China , today announced that it plans to release its second quarter 2010 financial...

TOPICS:

Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with Bioabsorbable Polymer and Everolimus Drug Coating

August 3, 2010 4:35 am | by Boston Scientific | News | Comments

EVOLVE trial to evaluate Company's fourth-generation SYNERGY™ drug-eluting coronary stent

TOPICS:

Concord Medical to Report Second Quarter 2010 Financial Results on Wednesday, August 18, 2010

August 3, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

BEIJING , Aug. 3 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical") (NYSE: CCM ), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will report its unaudited financial results for the...

TOPICS:
Advertisement

Dotted Eyes releases Contractor Portal v2.0 – the Definitive Data Sharing Platform

August 3, 2010 2:36 am | by RealWire | News | Comments

Shared access to asset data and aerial imagery sets the bar for 'data sharing without frontiers' in the new climate of local government collaborationBirmingham, 03 August 2010 - Dotted Eyes, the market leading GeoData and information software specialists, today announces the release of...

TOPICS:

News briefs from the August issue of Chest

August 2, 2010 9:33 pm | by EurekAlert | News | Comments

(American College of Chest Physicians) News briefs from the August issue of Chest discuss how diabetes may reduce lung function; how aerobic activity helps improve asthma symptoms; and how home sleep testing may be a viable option.

TOPICS:

For Eyes Optical Takes Man to Places He's Never Been Before in Humorous New TV Campaign

August 2, 2010 7:36 pm | by Bio-Medicine.Org | News | Comments

NEW YORK , Aug. 2 /- As eyewear is increasingly being marketed as a beauty and fashion product, For Eyes Optical rolls out a series of new television commercials for those who have lost sight of the fact that there's no need to pay for illusions that glasses can't deliver. Using the...

TOPICS:

DaVita 2Q profit rises as business expands

August 2, 2010 1:45 pm | by The Associated Press | News | Comments

Kidney dialysis services provider DaVita Inc. said Monday its net income edged up 2 percent in the second quarter as it expanded and provided more treatments.DaVita said its earnings rose to $107.9 million, or $1.04 per share, from $105.8 million, or $1.02 per share, a year ago. The latest...

Economic reports give stocks big start for August

August 2, 2010 1:45 pm | by STEPHEN BERNARD - AP Business Writer - Associated Press | News | Comments

The stock market began August with a huge rally after reports from around the world revived investors' faith in the global recovery.The Dow Jones industrial average rose 208 points Monday. All the major stock indexes rose about 2 percent.The first day of the month brought a stream of news that...

Advertisement

Nimodipine Oral Capsules: Medication Errors - IV Administration May Result in Death, Serious Harms

August 2, 2010 1:30 pm | by U.S. Food & Drug Administration | News | Comments

IV injection can result in cardiac arrest, severe falls in blood pressure, and other heart-related complications.

TOPICS:

Jeffrey Sprague, Founder, Vertical Research Partners LLC

August 2, 2010 10:45 am | by Ken PrewittAssociated Press | News | Comments

xfdfw BLOOMBERG-SURVEILLANC-03

Momenta's generic drug approval aids Q2 finances

August 2, 2010 10:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Momenta Pharmaceuticals Inc. is reporting that it narrowed its loss for the second quarter in the run up to its approval for its generic drug, enoxaparin, considered an alternative to Sanofi-Aventis’ Lovenox, an injectable drug to prevent and sometimes treat blood clots in the leg.

TOPICS:

New studies question vascular multiple sclerosis hypothesis and treatment

August 2, 2010 10:38 am | by EurekAlert | News | Comments

(Wiley-Blackwell) Two important new studies challenge the controversial hypothesis that venous congestion -- chronic cerebrospinal venous insufficiency (CCSVI) -- contributes to the development of multiple sclerosis. This theory has resulted in many MS patients receiving...

TOPICS:

Haemonetics lands blood management deal

August 2, 2010 10:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Haemonetics Corp. has formed a deal to provide its new blood management business intelligence portal, IMPACT Online, to member hospitals of Consorta Inc., a health-care group purchasing organization (GPO).

Repligen neuro research attracts major grant funding

August 2, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Waltham biopharmaceuticals firm Repligen Corp. has received three grants, totaling in excess of $6 million, to apply to its HDAC inhibitor research for neurodegenerative diseases like Friedreich’s Ataxia and Huntington’s Disease.

NeoProfen (ibuprofen lysine) Injection: Recall and Shortage - Risk of Particulate Matter

August 2, 2010 10:30 am | by U.S. Food & Drug Administration | News | Comments

Potential for particulate matter to result in serious adverse effects.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading